keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes. |
Synonyms | EGFRvIII peptide PEPvIII |
Molecular Weight | 1634.81 |
Formula | C70H111N19O24S |
CAS No. | 129112-17-0 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EGFRvIII peptide (PEPvIII) 129112-17-0 PEPvIII EGFRvIII peptide PEPvIII EGFRvIII peptide inhibitor inhibit